PAPER Månberg A, Skene N, Sanders F, Trusohamn M, Remnestål J, Szczepińska A, Aksoylu IS, Lönnerberg P, Ebarasi L, Wouters S, Lehmann M, Olofsson J, von Gohren Antequera I, Domaniku A, De Schaepdryver M, De Vocht J, Poesen K, Uhlén M, Anink J, Mijnsbergen C, Vergunst-Bosch H, Hübers A, Kläppe U, Rodriguez-Vieitez E, Gilthorpe JD, Hedlund E, Harris RA, Aronica E, Van Damme P, Ludolph A, Veldink J, Ingre C, Nilsson P, Lewandowski SA
SEARCH RESULTS
351 RESULTS
PAPER Szaruga M, Munteanu B, Lismont S, Veugelen S, Horré K, Mercken M, Saido TC, Ryan NS, De Vos T, Savvides SN, Gallardo R, Schymkowitz J, Rousseau F, Fox NC, Hopf C, De Strooper B, Chávez-Gutiérrez L
Alzheimer's-causing mutations shift Aβ length by destabilizing γ-secretase-Aβn interactions.
Cell. 2021 Apr 15;184(8):2257-2258. PubMed: 33861967PAPER Campbell S
The Search for a Drug to End Alzheimer's.
IEEE Pulse. 2021 Mar-Apr;12(2):2-7. PubMed: 33861693PAPER Atif M, Alsrhani A, Naz F, Imran M, Imran M, Ullah MI, Alameen AA, Gondal TA, Raza Q
Targeting Adenosine Receptors in Neurological Diseases.
Cell Reprogram. 2021 Apr;23(2):57-72. PubMed: 33861641PAPER Edison P
Brain Connectivity and Alzheimer's Disease.
Brain Connect. 2021 Apr;11(3):157-158. PubMed: 33861627PAPER Chauvin A, Baum S, Phillips NA
Individuals With Mild Cognitive Impairment and Alzheimer's Disease Benefit From Audiovisual Speech Cues and Supportive Sentence Context.
J Speech Lang Hear Res. 2021 May 11;64(5):1550-1559. Epub 2021 Apr 16 PubMed: 33861623PAPER Jang J, Park CB
Near-Infrared-Active Copper Molybdenum Sulfide Nanocubes for Phonon-Mediated Clearance of Alzheimer's β-Amyloid Aggregates.
ACS Appl Mater Interfaces. 2021 Apr 28;13(16):18581-18593. Epub 2021 Apr 16 PubMed: 33861570PAPER Hvid LG, Harwood DL, Eskildsen SF, Dalgas U
A Critical Systematic Review of Current Evidence on the Effects of Physical Exercise on Whole/Regional Grey Matter Brain Volume in Populations at Risk of Neurodegeneration.
Sports Med. 2021 Aug;51(8):1651-1671. Epub 2021 Apr 16 PubMed: 33861414PAPER Pan X, Sang S, Zhong C
Brain Energy Improvement as an Emerging Approach for Alzheimer's Disease Treatment.
Neurosci Bull. 2021 Jun;37(6):892-893. Epub 2021 Apr 16 PubMed: 33861413PAPER Wang X, Gu X, Li L, Yu B, Lv L, Chen Q, Xu M
An excellent electrochemical aptasensor for amyloid-β oligomers based on a triple-helix aptamer switch via target-triggered signal transduction DNA displacement events.
Anal Bioanal Chem. 2021 Jun;413(14):3707-3716. Epub 2021 Apr 16 PubMed: 33861355PAPER Wang Y, Wang Q, Han X, Ma Y, Zhang Z, Zhao L, Guan F, Ma S
Fucoidan: a promising agent for brain injury and neurodegenerative disease intervention.
Food Funct. 2021 May 11;12(9):3820-3830. PubMed: 33861265PAPER Wilson EN, Andreasson KI
TAM-ping down amyloid in Alzheimer's disease.
Nat Immunol. 2021 May;22(5):543-544. PubMed: 33859407PAPER Lochocki B, Boon BD, Verheul SR, Zada L, Hoozemans JJ, Ariese F, de Boer JF
Multimodal, label-free fluorescence and Raman imaging of amyloid deposits in snap-frozen Alzheimer's disease human brain tissue.
Commun Biol. 2021 Apr 15;4(1):474. PubMed: 33859370PAPER Mishra D, Dey CS
PKCα: Prospects in Regulating Insulin Resistance and AD.
Trends Endocrinol Metab. 2021 Jun;32(6):341-350. Epub 2021 Apr 12 PubMed: 33858742PAPER Degawa T, Kawahata I, Izumi H, Shinoda Y, Fukunaga K
T-type Ca2+ channel enhancer SAK3 administration improves the BPSD-like behaviors in AppNL-G-F/NL-G-F knock-in mice.
J Pharmacol Sci. 2021 May;146(1):1-9. Epub 2021 Feb 26 PubMed: 33858649Current Filters
- Date Range : Apr 2021 to Apr 2021 x